Sublobar Resection Produces Similar Outcomes as Lobectomy in T1aN0 NSCLC
Lobectomy and sublobar resection produce similar outcomes in patients with T1aN0 non-small cell lung cancer, a phase 3 study suggests.
Lobectomy and sublobar resection produce similar outcomes in patients with T1aN0 non-small cell lung cancer, a phase 3 study suggests.
A survey of US urologic oncologists suggests that reproductive organ-sparing and nerve-sparing radical cystectomy may be underused in women with bladder cancer.
Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.
Carboplatin and cisplatin are interchangeable in patients with limited-stage small-cell lung cancer undergoing chemoradiation, a real-world study suggests.
Adding HER-Vaxx to standard chemotherapy improves survival in patients with HER2-overexpressing, advanced gastric or GEJ cancer, a study suggests.
Adding zolbetuximab to standard frontline chemotherapy can improve outcomes in certain patients with gastric/GEJ cancer, a phase 3 study suggests.
US medical oncologists may lack understanding of biosimilars and have limited access to education about these products, a survey suggests.
Using telehealth saved cancer patients an estimated $147.40 to $186.10 per visit, as well as 1.2 hours of in-clinic time and 2.9 hours of roundtrip driving time.
Patients undergoing cancer surgery have an increased risk of suicide compared with the general population, a new study suggests.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.